Author:
Chen Rui,Zhang Yan,Zhao Chunyan
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference48 articles.
1. Gistera AHG. The immunology of atherosclerosis. Nat. Rev. Nephrol. 2017;13:368–80.
2. Khyzha N, Alizada A, Wilson MD, Fish JE. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol. Med. 2017;23:332–47.
3. Zhang BC, Li XK, Che WL, Li WM, Hou L, Wei YD, et al. Peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice. Zhonghua Xin Xue Guan Bing Za Zhi. 2013;41:143–9.
4. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.
5. Riccioni G, Sblendorio V. Atherosclerosis: from biology to pharmacological treatment. J. Geriatr. Cardiol. 2012;9:305–17.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献